8-K: Appian Appoints Carl Boe Hartman II to Board of Directors

Appian Corporation has appointed Carl Boe Hartman II, co-founder and CTO of Nomi Health, to its Board of Directors and Compensation Committee, effective October 1, 2024.

Summary

• Appian Corporation has appointed Carl Boe Hartman II to its Board of Directors, effective October 1, 2024.
• Mr. Hartman will also serve on the Compensation Committee.
• He is the Co-Founder and CTO of Nomi Health, a healthcare company.
• Prior to Nomi Health, Mr. Hartman held a leadership position at Goldman Sachs.
• The board has determined Mr. Hartman is independent.
• Mr. Hartman will receive an annual board service retainer of $250,000, half in cash and half in Appian stock.

Sentiment

Score: 7

Explanation: The appointment of a new board member is generally positive, especially given the appointee's background and experience. The sentiment is moderately positive.

Positives

• The appointment of Carl Boe Hartman II brings a technology innovator with experience in both healthcare and finance to the board.
• Mr. Hartman's experience as a former Appian customer provides a unique perspective.
• His background in digital transformation aligns with Appian's vision.
• The board has determined Mr. Hartman is independent, which is a positive for corporate governance.

Management Comments

• Boe Hartman stated that joining the Appian board aligns with his passion for creating simple, effective technology solutions that drive validated, measurable change.
• Matt Calkins, CEO of Appian, noted that Boe Hartman brings a distinct perspective as a former customer and technology innovator.

Industry Context

The appointment of a technology leader with experience in healthcare and finance reflects the growing importance of digital transformation and technology expertise in the software industry.

Comparison to Industry Standards

• The appointment of an independent director with a strong technology background is consistent with best practices in corporate governance.
• The compensation structure for board members, including a mix of cash and stock, is a common practice among publicly traded technology companies.
• Appian's board composition is similar to other software companies that seek to balance industry expertise with financial acumen.

Management Changes

Stakeholder Impact

• Shareholders may view the appointment of a technology leader positively.
• Employees may see this as a positive step for the company's future.
• Customers may benefit from the board's increased technology expertise.

Next Steps

• Mr. Hartman will serve on the Board of Directors until the 2025 annual meeting of stockholders.
• Mr. Hartman will participate in the Compensation Committee.

Key Dates

Keywords

Board of Directors, Corporate Governance, Technology, Appointment, Compensation Committee, Digital Transformation, Healthcare, Finance